NASDAQ:ECOR electroCore Q3 2026 Earnings Date & Estimates $9.30 -0.36 (-3.67%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. electroCore is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 4, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from electroCore in Q3 2026electroCore is expected to post earnings of -$0.26 per share on revenue of $10.93 million. In the same quarter a year earlier electroCore reported -$0.40 per share on revenue of $8.69 million. electroCore last reported on August 6, 2026, posting -$0.33 per share and beating the -$0.4218 consensus estimate. electroCore has beaten the consensus EPS estimate in 4 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.26Expected Revenue$10.93 millionPrior-Year EPS-$0.40Prior-Year Revenue$8.69 millionExpected Revenue Growth+25.8%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.33 (Beat by +$0.0918)Last Quarter Revenue$9.45 millionEPS Beat Rate4 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report electroCore Q3 2026 Earnings FAQ When does electroCore report Q3 2026 earnings? electroCore (NASDAQ:ECOR) is estimated to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is electroCore's Q3 2026 earnings call? electroCore's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for electroCore? Analysts expect electroCore to post earnings of -$0.26 per share for Q3 2026. How much revenue is electroCore expected to report? The consensus revenue estimate for electroCore is $10.93 million for Q3 2026. electroCore Earnings HeadlineselectroCore (NASDAQ:ECOR) and iRhythm Technologies (NASDAQ:IRTC) Head to Head AnalysisOctober 12 at 3:58 AM | americanbankingnews.comContrasting electroCore (NASDAQ:ECOR) & Enovis (NYSE:ENOV)October 6, 2026 | americanbankingnews.comTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may be a bid to reset the US dollar. Porter Stansberry says the meeting, attended by figures like Elon Musk, Jensen Huang and Larry Fink, connects to a 13-nation pact designed to cut China out of a massive investment wave.October 12 at 1:00 AM | Porter & Company (Ad)electroCore Has A Line Of Sight At Cash BreakevenSeptember 26, 2026 | seekingalpha.comelectroCore to Participate at H.C. Wainwright Global Investment ConferenceSeptember 10, 2026 | globenewswire.comElectroCore appoints Joshua Lev and Mike Fox as co-CEOsSeptember 9, 2026 | msn.comSee More electroCore Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like electroCore? Sign up for Earnings360's daily newsletter to receive timely earnings updates on electroCore and other key companies, straight to your email. Email Address About electroCoreelectroCore (NASDAQ:ECOR) is a commercial-stage medical device company that develops and markets non-invasive vagus nerve stimulation (nVNS) therapies. Its technology is designed to stimulate the vagus nerve through the skin of the neck without requiring surgery or implanted hardware. The company’s primary prescription product is gammaCore, a handheld device used to deliver nVNS therapy. GammaCore has received regulatory clearances for certain migraine and cluster headache indications and is marketed as an option for the acute treatment of associated pain, with additional uses depending on the applicable regulatory authorization. electroCore also markets Truvaga, a consumer-focused vagus nerve stimulation device intended for general wellness applications. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey. Its products have been marketed in the United States and through international commercial and distribution channels.View electroCore ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 5 Retail Picks to Watch as the Holiday Shopping Season NearsMarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsC.H. Robinson Bets Its AI Story on RXO—But the Market Isn't SoldApplied Digital’s Hidden Moat Could Unlock Massive Upside Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
